Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METFORMIN CAFFEIC ACID SALT, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND COMBINED FORMULATION COMPRISING SAME
Document Type and Number:
WIPO Patent Application WO/2011/025270
Kind Code:
A2
Abstract:
The present invention relates to a metformin caffeic acid salt, to a method for preparing same, to a pharmaceutical composition comprising same, and to a combined formulation comprising same. The metformin caffeic acid salt of the present invention has superior stability, enables easy tabletting, and has low toxicity, thus can be valuably used in the treatment of glycosuria, diabetes, metabolic syndrome, diabetes complications, menstrual irregularities, hypertension, hyperlipidemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovary syndrome, cancer, myalgia, symptoms of muscle cell cytotoxicity, rhabdomyolysis, climacterium, etc., and/or provides antioxidant activity.

Inventors:
KIM SUNG WUK (KR)
JUN SUNG SOO (KR)
MIN CHANGHEE (KR)
KOO JA SEONG (KR)
KANG MIN SEOK (KR)
KIM YONG EUN (KR)
Application Number:
PCT/KR2010/005712
Publication Date:
March 03, 2011
Filing Date:
August 25, 2010
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HANALL BIOPHARMA CO LTD (KR)
KIM SUNG WUK (KR)
JUN SUNG SOO (KR)
MIN CHANGHEE (KR)
KOO JA SEONG (KR)
KANG MIN SEOK (KR)
KIM YONG EUN (KR)
International Classes:
C07C279/26; A61K31/155; A61K31/192; C07C59/11
Domestic Patent References:
WO2008112167A12008-09-18
WO2005092311A12005-10-06
Foreign References:
KR100774774B12007-11-07
Other References:
HUANG, N-L ET AL.: 'Metformin inhibits TNF-alpha-induced IkB kinase phosphorylation, IkB-alpha degradation and IL-6 production in endothelialcells through PI3K-dependent AMPK phosphorylation' INTERNATIONAL JOURNAL OF CARDIOLOGY vol. 134, 15 May 2009, pages 169 - 175
Attorney, Agent or Firm:
AHN, So-Young (KR)
안소영 (KR)
Download PDF: